CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Palliative cancer care - nausea & vomiting - Management
Levomepromazine (oral or parenteral)
Age from 16 years onwards
Levomepromazine tablets: 6.25mg at night and when required
Levomepromazine 25mg tablets
Take a quarter of a tablet at night AND when required to relieve nausea and vomiting.
Supply 7 tablets.
Levomepromazine subcutaneous inj: 6.25-12.5mg daily
Levomepromazine 25mg/1ml solution for injection ampoules
FOR SUBCUTANEOUS INJECTION. Give 0.25ml (6.25mg) once a day AND when required to relieve nausea and vomiting.
Supply 3 1ml ampoules.
Levomepromazine subcutaneous infusion: give 5-25mg over 24 hours
Levomepromazine 25mg/1ml solution for injection ampoules
FOR CONTINUOUS SUBCUTANEOUS INFUSION. Give 0.2ml (5mg) to 1ml (25mg) over 24 hours via a syringe driver.
Supply 3 1ml ampoules.
© NHS Institute for Innovation and Improvement